Latest On InVivo Therapeutics Holdings Corp (NVIV):
About InVivo Therapeutics Holdings Corp (NVIV):
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
General
- Name InVivo Therapeutics Holdings Corp
- Symbol NVIV
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 6
- Last Split Factor1:30
- Last Split Date2020-02-12
- Fiscal Year EndDecember
- IPO Date2010-10-29
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.invivotherapeutics.com
Valuation
- Price/Book (Most Recent Quarter) 2
- Enterprise Value EBITDA 0.59
Financials
- Most Recent Quarter 2020-12-31
- Return on Assets -36%
- Return on Equity -73%
- Earnings Per Share -$1.30
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 37.6 million
- EBITDA -11084000
- Analyst Target Price $37.5
- Book Value Per Share $0.81
Share Statistics
- Shares Outstanding 34.18 million
- Shares Float 34.17 million
- % Held by Insiders 1235%
- % Held by Institutions 7.09%
- Shares Short 3.48 million
- Shares Short Prior Month 4.12 million
- Short Ratio 0.58
- Short % of Float 10%
- Short % of Shares Outstanding 10%
Technicals
- Beta 1.71
- 52 Week High $2.55
- 52 Week Low $0.5
- 50 Day Moving Average 1.3
- 200 Day Moving Average 1.04
Dividends
- Dividend Date 2020-02-12
- ExDividend Date N/A
- Dividend Yield 0%
InVivo Therapeutics Holdings Corp (NVIV) Dividend Calendar:
NVIV's last dividend payment was made to shareholders on February 12, 2020.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
InVivo Therapeutics Holdings Corp (NVIV) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-03-03 | $N/A | -$0.09 | ||
2020-09-30 | 2020-12-31 | $N/A | -$0.13 | ||
2020-06-30 | 2020-09-30 | $N/A | -$0.47 | ||
2020-03-31 | 2020-06-30 | $N/A | -$0.49 | -$5.40 | 90.9% |
2019-12-31 | 2020-03-31 | $N/A | -$2.47 | -$9.00 | 72.52% |
2019-09-30 | 2019-11-07 | $N/A | -$8.70 | -$9.90 | 12.12% |
2019-06-30 | 2019-08-13 | $N/A | -$10.20 | -$9.30 | -9.68% |
2019-03-31 | 2019-05-10 | $N/A | -$8.40 | -$8.70 | 3.45% |
2018-12-31 | 2018-12-31 | $N/A | -$15.30 | -$10.20 | -50% |
2018-09-30 | 2018-11-08 | $N/A | -$12.60 | -$11.40 | -10.53% |
2018-06-30 | 2018-08-07 | $N/A | -$224.40 | -$12.30 | -1724.39% |
2018-03-31 | 2018-05-07 | $N/A | -$100.20 | -$112.50 | 10.93% |
2017-12-31 | 2018-03-12 | $N/A | -$97.50 | -$120.00 | 18.75% |
2017-09-30 | 2017-10-30 | $N/A | -$210.00 | -$165.00 | -27.27% |
2017-06-30 | 2017-08-08 | $N/A | -$150.00 | -$153.75 | 2.44% |
2017-03-31 | 2017-05-04 | $N/A | -$150.00 | -$161.25 | 6.98% |
2016-12-31 | 2017-03-10 | $N/A | -$127.50 | -$147.50 | 13.56% |
2016-09-30 | 2016-11-04 | $N/A | -$142.50 | -$147.50 | 3.39% |
2016-06-30 | 2016-08-04 | $N/A | -$120.00 | -$159.38 | 24.71% |
2016-03-31 | 2016-05-06 | $N/A | -$180.00 | -$195.00 | 7.69% |
2015-12-31 | 2016-03-04 | $N/A | -$105.00 | -$165.00 | 36.36% |
2015-09-30 | 2015-11-04 | $N/A | -$64.09 | ||
2015-06-30 | 2015-08-05 | $N/A | -$0.39 | -$0.20 | -95% |
2015-03-31 | 2015-05-07 | $N/A | -$0.64 | -$0.05 | -1180% |
2014-12-31 | 2015-03-11 | $N/A | -$0.36 | -$0.16 | -125% |
2014-09-30 | 2014-11-05 | $N/A | -$0.04 | -$0.20 | 80% |
2014-06-30 | 2014-08-06 | $N/A | -$120.00 | -$180.00 | 33.33% |
2014-03-31 | 2014-05-12 | $N/A | -$210.00 | -$240.00 | 12.5% |
2013-12-31 | 2014-03-17 | $N/A | -$180.00 | -$240.00 | 25% |
2013-09-30 | 2013-11-07 | $N/A | -$210.00 | -$210.00 | 0% |
2013-06-30 | 2013-08-07 | $N/A | -$570.00 | -$210.00 | -171.43% |
2013-03-31 | 2013-05-09 | $N/A | -$600.00 | -$210.00 | -185.71% |
2012-12-31 | 2013-03-13 | $N/A | -$390.00 | -$150.00 | -160% |
2012-09-30 | 2012-11-14 | $N/A | -$120.00 | -$150.00 | 20% |
2012-06-30 | 2012-08-14 | $N/A | -$120.00 | -$120.00 | 0% |
2012-03-31 | 2012-05-30 | $N/A | $136.93 | ||
2011-12-31 | 2012-02-29 | $N/A | -$2,031.83 | ||
2011-09-30 | 2011-09-30 | $N/A | $169.54 | ||
2011-06-30 | 2011-06-30 | $N/A | -$79.54 | ||
2011-03-31 | 2011-03-31 | $N/A | -$74.21 |
InVivo Therapeutics Holdings Corp (NVIV) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
InVivo Therapeutics Holdings Corp (NVIV) Chart:
InVivo Therapeutics Holdings Corp (NVIV) News:
Below you will find a list of latest news for InVivo Therapeutics Holdings Corp (NVIV) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
InVivo Therapeutics Holdings Corp (NVIV) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest NVIV Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 2:47 PM EST | 100 | $3.81 |
Jun 13, 2022 3:38 PM EST | 100 | $3.83 |
Jun 13, 2022 3:38 PM EST | 100 | $3.83 |
InVivo Therapeutics Holdings Corp (NVIV) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911020007730/0001179110-20-007730-index.htm |
2019-09-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1292519/000000000019013074/0000000000-19-013074-index.htm |
2019-09-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1292519/000000000019013550/0000000000-19-013550-index.htm |
2019-11-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1292519/000000000019015108/0000000000-19-015108-index.htm |
2020-02-28 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1292519/000000000020001848/0000000000-20-001848-index.htm |
2020-03-02 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1292519/000000000020001888/0000000000-20-001888-index.htm |
2020-06-01 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1292519/000000000020004850/0000000000-20-004850-index.htm |
2020-03-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000091957420002457/0000919574-20-002457-index.htm |
2020-04-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000091957420003022/0000919574-20-003022-index.htm |
2020-10-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000092963820001017/0000929638-20-001017-index.htm |
2019-10-28 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1292519/000104746919005932/0001047469-19-005932-index.htm |
2019-11-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1292519/000104746919006349/0001047469-19-006349-index.htm |
2019-11-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1292519/000104746919006460/0001047469-19-006460-index.htm |
2020-02-21 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1292519/000104746920000997/0001047469-20-000997-index.htm |
2020-03-02 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1292519/000104746920001151/0001047469-20-001151-index.htm |
2020-03-05 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1292519/000104746920001217/0001047469-20-001217-index.htm |
2020-03-09 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1292519/000104746920001325/0001047469-20-001325-index.htm |
2020-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000104746920001394/0001047469-20-001394-index.htm |
2020-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000104746920002367/0001047469-20-002367-index.htm |
2020-04-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1292519/000104746920002369/0001047469-20-002369-index.htm |
2020-05-22 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1292519/000104746920003187/0001047469-20-003187-index.htm |
2020-06-04 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000104746920003362/0001047469-20-003362-index.htm |
2018-06-22 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1292519/000110465918041756/0001104659-18-041756-index.htm |
2018-06-26 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1292519/000110465918042287/0001104659-18-042287-index.htm |
2018-06-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000110465918043038/0001104659-18-043038-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000110465919008600/0001104659-19-008600-index.htm |
2019-06-21 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1292519/000110465919036827/0001104659-19-036827-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465919062061/0001104659-19-062061-index.htm |
2019-11-12 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1292519/000110465919062128/0001104659-19-062128-index.htm |
2019-11-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1292519/000110465919063133/0001104659-19-063133-index.htm |
2019-11-21 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000110465919065989/0001104659-19-065989-index.htm |
2019-11-21 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000110465919065990/0001104659-19-065990-index.htm |
2019-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465919065991/0001104659-19-065991-index.htm |
2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465919066352/0001104659-19-066352-index.htm |
2019-12-10 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465919071457/0001104659-19-071457-index.htm |
2020-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920004757/0001104659-20-004757-index.htm |
2020-01-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920006733/0001104659-20-006733-index.htm |
2020-02-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920009800/0001104659-20-009800-index.htm |
2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920016725/0001104659-20-016725-index.htm |
2020-02-24 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920024279/0001104659-20-024279-index.htm |
2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920027863/0001104659-20-027863-index.htm |
2020-03-03 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1292519/000110465920028575/0001104659-20-028575-index.htm |
2020-04-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000110465920050797/0001104659-20-050797-index.htm |
2020-06-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1292519/000110465920068597/0001104659-20-068597-index.htm |
2020-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920070292/0001104659-20-070292-index.htm |
2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920090878/0001104659-20-090878-index.htm |
2020-10-07 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1292519/000110465920112754/0001104659-20-112754-index.htm |
2020-10-16 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1292519/000110465920115633/0001104659-20-115633-index.htm |
2020-10-26 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1292519/000110465920117863/0001104659-20-117863-index.htm |
2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000110465920117865/0001104659-20-117865-index.htm |
2020-11-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1292519/000110465920122534/0001104659-20-122534-index.htm |
2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911018014176/0001179110-18-014176-index.htm |
2019-01-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019000765/0001179110-19-000765-index.htm |
2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019000766/0001179110-19-000766-index.htm |
2019-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019000859/0001179110-19-000859-index.htm |
2019-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019002139/0001179110-19-002139-index.htm |
2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019004125/0001179110-19-004125-index.htm |
2019-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019005165/0001179110-19-005165-index.htm |
2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019006512/0001179110-19-006512-index.htm |
2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019008009/0001179110-19-008009-index.htm |
2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019010713/0001179110-19-010713-index.htm |
2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019010714/0001179110-19-010714-index.htm |
2019-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019010715/0001179110-19-010715-index.htm |
2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911019013127/0001179110-19-013127-index.htm |
2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911020003589/0001179110-20-003589-index.htm |
2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911020003590/0001179110-20-003590-index.htm |
2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911020003591/0001179110-20-003591-index.htm |
2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1292519/000117911020007730/0001179110-20-007730-index.htm |
2018-06-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000119312518202479/0001193125-18-202479-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000119312519040169/0001193125-19-040169-index.htm |
2020-11-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000119380520001368/0001193805-20-001368-index.htm |
2020-04-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000121390020010045/0001213900-20-010045-index.htm |
2020-04-28 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1292519/000129251920000002/0001292519-20-000002-index.htm |
2018-06-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000153561018000091/0001535610-18-000091-index.htm |
2019-01-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000153561019000037/0001535610-19-000037-index.htm |
2020-04-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000153561020000088/0001535610-20-000088-index.htm |
2020-11-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1292519/000155335020000963/0001553350-20-000963-index.htm |
2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018006578/0001558370-18-006578-index.htm |
2018-08-07 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018006619/0001558370-18-006619-index.htm |
2018-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007171/0001558370-18-007171-index.htm |
2018-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007575/0001558370-18-007575-index.htm |
2018-09-28 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007601/0001558370-18-007601-index.htm |
2018-09-28 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007602/0001558370-18-007602-index.htm |
2018-09-28 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007603/0001558370-18-007603-index.htm |
2018-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007644/0001558370-18-007644-index.htm |
2018-10-05 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007647/0001558370-18-007647-index.htm |
2018-10-05 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007648/0001558370-18-007648-index.htm |
2018-10-05 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018007651/0001558370-18-007651-index.htm |
2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018008996/0001558370-18-008996-index.htm |
2018-11-08 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009003/0001558370-18-009003-index.htm |
2018-11-08 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009007/0001558370-18-009007-index.htm |
2018-11-08 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009011/0001558370-18-009011-index.htm |
2018-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009227/0001558370-18-009227-index.htm |
2018-11-13 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009229/0001558370-18-009229-index.htm |
2018-11-13 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009231/0001558370-18-009231-index.htm |
2018-11-13 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009234/0001558370-18-009234-index.htm |
2018-11-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009403/0001558370-18-009403-index.htm |
2018-11-16 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009405/0001558370-18-009405-index.htm |
2018-11-16 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009407/0001558370-18-009407-index.htm |
2018-11-16 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009411/0001558370-18-009411-index.htm |
2018-12-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009701/0001558370-18-009701-index.htm |
2018-12-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009703/0001558370-18-009703-index.htm |
2018-12-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009705/0001558370-18-009705-index.htm |
2018-12-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837018009707/0001558370-18-009707-index.htm |
2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837019000048/0001558370-19-000048-index.htm |
2019-01-04 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019000049/0001558370-19-000049-index.htm |
2019-01-04 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019000052/0001558370-19-000052-index.htm |
2019-01-04 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019000053/0001558370-19-000053-index.htm |
2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837019000142/0001558370-19-000142-index.htm |
2019-01-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019000145/0001558370-19-000145-index.htm |
2019-01-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019000147/0001558370-19-000147-index.htm |
2019-01-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019000148/0001558370-19-000148-index.htm |
2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019002671/0001558370-19-002671-index.htm |
2019-04-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1292519/000155837019002673/0001558370-19-002673-index.htm |
2019-04-15 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1292519/000155837019003007/0001558370-19-003007-index.htm |
2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1292519/000155837019003326/0001558370-19-003326-index.htm |
2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019004777/0001558370-19-004777-index.htm |
2019-05-17 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1292519/000155837019005188/0001558370-19-005188-index.htm |
2019-06-05 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1292519/000155837019005502/0001558370-19-005502-index.htm |
2019-06-05 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1292519/000155837019005504/0001558370-19-005504-index.htm |
2019-06-14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1292519/000155837019005695/0001558370-19-005695-index.htm |
2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837019005696/0001558370-19-005696-index.htm |
2019-07-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837019006018/0001558370-19-006018-index.htm |
2019-07-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837019006077/0001558370-19-006077-index.htm |
2019-07-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1292519/000155837019006079/0001558370-19-006079-index.htm |
2019-07-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837019006165/0001558370-19-006165-index.htm |
2019-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019008016/0001558370-19-008016-index.htm |
2019-09-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1292519/000155837019008578/0001558370-19-008578-index.htm |
2019-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1292519/000155837019008723/0001558370-19-008723-index.htm |
2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837019010402/0001558370-19-010402-index.htm |
2019-11-08 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1292519/000155837019010629/0001558370-19-010629-index.htm |
2019-11-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1292519/000155837019011221/0001558370-19-011221-index.htm |
2020-02-20 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1292519/000155837020001077/0001558370-20-001077-index.htm |
2020-02-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1292519/000155837020001097/0001558370-20-001097-index.htm |
2020-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837020006492/0001558370-20-006492-index.htm |
2020-06-09 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1292519/000155837020007390/0001558370-20-007390-index.htm |
2020-06-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1292519/000155837020007677/0001558370-20-007677-index.htm |
2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837020010328/0001558370-20-010328-index.htm |
2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1292519/000155837020013154/0001558370-20-013154-index.htm |
2019-05-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1292519/999999999519001218/9999999995-19-001218-index.htm |
2019-06-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1292519/999999999519001468/9999999995-19-001468-index.htm |
2019-11-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1292519/999999999519002574/9999999995-19-002574-index.htm |
2020-03-06 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1292519/999999999520000479/9999999995-20-000479-index.htm |
2020-06-04 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1292519/999999999520001343/9999999995-20-001343-index.htm |
2020-10-22 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1292519/999999999520002952/9999999995-20-002952-index.htm |
InVivo Therapeutics Holdings Corp (NVIV) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of InVivo Therapeutics Holdings Corp (NVIV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1235%Institutional Ownership: 709%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-06-04 | Richard M. Toselli | Officer | Sell | 5,229.00 | 0.97 | 5,072.13 | 0.00 | https://www.sec.gov/Archives/edgar/data/1292519/000117911019010715/0001179110-19-010715-index.htm |
2018-12-18 | Richard M. Toselli | Officer | Buy | 12,000.00 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1292519/000117911018014176/0001179110-18-014176-index.htm | ||
2020-03-10 | C ANN MERRIFIELD | Director | Buy | 3,636.00 | 3,639.00 | https://www.sec.gov/Archives/edgar/data/1292519/000117911020003589/0001179110-20-003589-index.htm | ||
2019-09-25 | RICHARD CHRISTOPHER | CFO and Treasurer | Buy | 47,500.00 | 47,500.00 | https://www.sec.gov/Archives/edgar/data/1292519/000117911019010713/0001179110-19-010713-index.htm | ||
2020-03-10 | RICHARD CHRISTOPHER | CFO and Treasurer | Buy | 3,636.00 | 5,220.00 | https://www.sec.gov/Archives/edgar/data/1292519/000117911020003590/0001179110-20-003590-index.htm | ||
2020-03-10 | Richard M. Toselli | Officer | Buy | 3,636.00 | 6,069.00 | https://www.sec.gov/Archives/edgar/data/1292519/000117911020003591/0001179110-20-003591-index.htm | ||
2019-09-25 | Richard M. Toselli | Officer | Buy | 69,000.00 | 79,543.00 | https://www.sec.gov/Archives/edgar/data/1292519/000117911019010714/0001179110-19-010714-index.htm |